<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Hanley, Daniel F.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Final Results of the Clear IVH Trial: Clot Lysis, Safety and 180 Day Functional Outcomes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">13-14</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses the 180-day data from the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage [CLEAR; NCT00784134] study, which showed that the combination of extraventricular drainage plus thrombolysis with the thrombolytic rt-PA substantially reduces mortality and poor outcomes in patients with intraventricular hemorrhage.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>